• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

平滑肌中蛋白磷酸酶-1新型磷酸化依赖性抑制蛋白(CPI17)的分子克隆:其在平滑肌中的特异性定位。

Molecular cloning of a novel phosphorylation-dependent inhibitory protein of protein phosphatase-1 (CPI17) in smooth muscle: its specific localization in smooth muscle.

作者信息

Eto M, Senba S, Morita F, Yazawa M

机构信息

Division of Chemistry, Graduate School of Science, Hokkaido University, Sapporo, Japan.

出版信息

FEBS Lett. 1997 Jun 30;410(2-3):356-60. doi: 10.1016/s0014-5793(97)00657-1.

DOI:10.1016/s0014-5793(97)00657-1
PMID:9237662
Abstract

The cDNA encoding a phosphorylation-dependent inhibitory protein of protein phosphatase-1 (PP1) was isolated from a porcine aorta library. The coding region represented the complete amino acid sequence of this protein comprised of a novel 147-residue polypeptide, which we termed CPI17, a 17-kDa PKC-potentiated inhibitory protein of PP1. As well as the native CPI17 from porcine aorta, the recombinant protein completely suppressed the PP1 activity (IC50 = 0.18 nM) by the stoichiometric thiophosphorylation. The CPI17 mRNA is expressed in smooth muscle tissues such as aorta and bladder, whereas little expression was observed in heart, skeletal muscle, and non-muscle tissues. These results suggest a specific regulatory mechanism of the PP1 activity through CPI17 in smooth muscle.

摘要

从猪主动脉文库中分离出编码蛋白磷酸酶-1(PP1)磷酸化依赖性抑制蛋白的cDNA。编码区代表了该蛋白完整的氨基酸序列,其由一个新的147个残基的多肽组成,我们将其命名为CPI17,这是一种17 kDa的蛋白激酶C增强的PP1抑制蛋白。与来自猪主动脉的天然CPI17一样,重组蛋白通过化学计量的硫代磷酸化完全抑制了PP1活性(IC50 = 0.18 nM)。CPI17 mRNA在主动脉和膀胱等平滑肌组织中表达,而在心脏、骨骼肌和非肌肉组织中几乎没有表达。这些结果表明平滑肌中存在通过CPI17对PP1活性的特定调节机制。

相似文献

1
Molecular cloning of a novel phosphorylation-dependent inhibitory protein of protein phosphatase-1 (CPI17) in smooth muscle: its specific localization in smooth muscle.平滑肌中蛋白磷酸酶-1新型磷酸化依赖性抑制蛋白(CPI17)的分子克隆:其在平滑肌中的特异性定位。
FEBS Lett. 1997 Jun 30;410(2-3):356-60. doi: 10.1016/s0014-5793(97)00657-1.
2
Identification of trimeric myosin phosphatase (PP1M) as a target for a novel PKC-potentiated protein phosphatase-1 inhibitory protein (CPI17) in porcine aorta smooth muscle.在猪主动脉平滑肌中鉴定三聚体肌球蛋白磷酸酶(PP1M)作为新型蛋白激酶C增强的蛋白磷酸酶-1抑制蛋白(CPI17)的作用靶点。
J Biochem. 1999 Feb;125(2):354-62. doi: 10.1093/oxfordjournals.jbchem.a022294.
3
Identification of human CPI-17, an inhibitory phosphoprotein for myosin phosphatase.人CPI-17的鉴定,一种肌球蛋白磷酸酶的抑制性磷蛋白。
Biochem Biophys Res Commun. 2001 Jul 27;285(4):1040-5. doi: 10.1006/bbrc.2001.5290.
4
Agonist-induced changes in the phosphorylation of the myosin- binding subunit of myosin light chain phosphatase and CPI17, two regulatory factors of myosin light chain phosphatase, in smooth muscle.激动剂诱导的平滑肌中肌球蛋白轻链磷酸酶的肌球蛋白结合亚基和CPI17(肌球蛋白轻链磷酸酶的两个调节因子)磷酸化的变化。
Biochem J. 2003 Jan 1;369(Pt 1):117-28. doi: 10.1042/BJ20021040.
5
KEPI, a PKC-dependent protein phosphatase 1 inhibitor regulated by morphine.KEPI,一种受吗啡调节的蛋白激酶C依赖性蛋白磷酸酶1抑制剂。
J Biol Chem. 2002 Apr 12;277(15):13312-20. doi: 10.1074/jbc.M107558200. Epub 2002 Jan 25.
6
Multiple structural elements define the specificity of recombinant human inhibitor-1 as a protein phosphatase-1 inhibitor.多种结构元件决定了重组人抑制剂-1作为蛋白磷酸酶-1抑制剂的特异性。
Biochemistry. 1996 Apr 23;35(16):5220-8. doi: 10.1021/bi952940f.
7
Phosphorylation of CPI17 and myosin binding subunit of type 1 protein phosphatase by p21-activated kinase.p21激活激酶对CPI17和1型蛋白磷酸酶的肌球蛋白结合亚基的磷酸化作用。
Biochem Biophys Res Commun. 2002 Oct 4;297(4):773-8. doi: 10.1016/s0006-291x(02)02302-1.
8
GBPI, a novel gastrointestinal- and brain-specific PP1-inhibitory protein, is activated by PKC and inactivated by PKA.GBPI是一种新型的胃肠道和脑特异性蛋白磷酸酶1抑制蛋白,被蛋白激酶C激活,被蛋白激酶A失活。
Biochem J. 2004 Jan 1;377(Pt 1):171-81. doi: 10.1042/BJ20030128.
9
A novel phosphoprotein inhibitor of protein type-1 phosphatase holoenzymes.一种新型的蛋白1型磷酸酶全酶磷蛋白抑制剂。
Biochemistry. 1999 Dec 21;38(51):16952-7. doi: 10.1021/bi992030o.
10
Characterization of the inhibition of protein phosphatase-1 by DARPP-32 and inhibitor-2.DARPP-32和抑制剂-2对蛋白磷酸酶-1的抑制作用表征
J Biol Chem. 1999 Mar 19;274(12):7870-8. doi: 10.1074/jbc.274.12.7870.

引用本文的文献

1
LIMK2-1 Is a Phosphorylation-Dependent Inhibitor of Protein Phosphatase-1 Catalytic Subunit and Myosin Phosphatase Holoenzyme.LIMK2-1是蛋白磷酸酶-1催化亚基和肌球蛋白磷酸酶全酶的磷酸化依赖性抑制剂。
Int J Mol Sci. 2025 Jul 30;26(15):7347. doi: 10.3390/ijms26157347.
2
Rediscovery of PHI-1/PPP1R14B: Emerging Roles of Cellular PP1 Signaling Mediated by the Gene Product in Multiple Cancers and Beyond.PHI-1/PPP1R14B的重新发现:该基因产物介导的细胞蛋白磷酸酶1信号在多种癌症及其他领域的新作用
Biomolecules. 2025 Feb 27;15(3):344. doi: 10.3390/biom15030344.
3
The role of RhoA-ROCK signaling in benign prostatic hyperplasia: a review.
RhoA-ROCK信号通路在良性前列腺增生中的作用:综述
Hum Cell. 2025 Feb 1;38(2):48. doi: 10.1007/s13577-025-01179-x.
4
The interplay between alterations in esophageal microbiota associated with Th17 immune response and impaired LC20 phosphorylation in achalasia.食管微生物群与 Th17 免疫反应改变以及 Achalasia 中 LC20 磷酸化受损之间的相互作用。
J Gastroenterol. 2024 May;59(5):361-375. doi: 10.1007/s00535-024-02088-w. Epub 2024 Mar 12.
5
Calponin 1 inhibits agonist-induced ERK activation and decreases calcium sensitization in vascular smooth muscle.钙调节蛋白 1 抑制激动剂诱导的 ERK 激活,并降低血管平滑肌的钙敏化。
J Cell Mol Med. 2024 Jan;28(1):e18025. doi: 10.1111/jcmm.18025. Epub 2023 Dec 26.
6
Altered functional responses by PAR1 agonist in murine dextran sodium sulphate-treated colon.PAR1 激动剂在葡聚糖硫酸钠处理的小鼠结肠中的功能反应改变。
Sci Rep. 2022 Oct 6;12(1):16746. doi: 10.1038/s41598-022-21285-2.
7
Possible roles of N- and C-terminal unstructured tails of CPI-17 in regulating Ca sensitization force of smooth muscle.CPI-17 的 N-和 C-末端无规则尾部在调节平滑肌钙敏化力中的可能作用。
J Smooth Muscle Res. 2022;58(0):22-33. doi: 10.1540/jsmr.58.22.
8
Age-associated changes in microglia and astrocytes ameliorate blood-brain barrier dysfunction.小胶质细胞和星形胶质细胞的年龄相关变化改善血脑屏障功能障碍。
Mol Ther Nucleic Acids. 2021 Sep 7;26:970-986. doi: 10.1016/j.omtn.2021.08.030. eCollection 2021 Dec 3.
9
Regulation of myosin light-chain phosphorylation and its roles in cardiovascular physiology and pathophysiology.肌球蛋白轻链磷酸化的调节及其在心血管生理学和病理生理学中的作用。
Hypertens Res. 2022 Jan;45(1):40-52. doi: 10.1038/s41440-021-00733-y. Epub 2021 Oct 6.
10
Thomas Willis Lecture: Targeting Brain Arterioles for Acute Stroke Treatment.托马斯·威利斯讲座:急性脑卒中治疗的靶向脑动脉。
Stroke. 2021 Jul;52(7):2465-2477. doi: 10.1161/STROKEAHA.121.034620. Epub 2021 Jun 9.